Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference


Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45th Annual Health

Chevron Announces Senior Leadership Changes
Chevron Announces Senior Leadership Changes


Chevron Corporation (NYSE: CVX) today announced senior leadership changes as part of the company’s efforts to simplify its organizational structure, execute faster and more effectively, and be

NIKE, Inc. Announces Third Quarter Fiscal 2025 Earnings and Conference Call:
NIKE, Inc. Announces Third Quarter Fiscal 2025 Earnings and Conference Call


NIKE, Inc. (NYSE: NKE) plans to release its third quarter fiscal 2025 financial results on Thursday, March 20, 2025, at approximately 1:15 p.m. PT, following the close of regular stock market

Walmart reports strong revenue of 4.1%, up 5.3% in constant currency (cc) with operating income growing faster at 8.3%, or 9.4% adjusted (cc)
Walmart reports strong revenue of 4.1%, up 5.3% in constant currency (cc) with operating income growing faster at 8.3%, or 9.4% adjusted (cc)


Walmart Inc. (NYSE: WMT):


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219052528/en/



Fourth Quarter Highlights:




  • Revenue of

Walmart Raises Annual Dividend 13 Percent to $0.94 Per Share, Marking 52nd Consecutive Year of Dividend Increases
Walmart Raises Annual Dividend 13 Percent to $0.94 Per Share, Marking 52nd Consecutive Year of Dividend Increases


The Board of Directors of Walmart Inc. (NYSE: WMT) approved an annual cash dividend for fiscal year 2026 of $0.94 per share. This represents a 13 percent increase from the $0.83 per share paid for

NIKE, Inc. Declares $0.40 Quarterly Dividend:
NIKE, Inc. Declares $0.40 Quarterly Dividend


NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per share on the Company’s outstanding Class A and Class B Common Stock payable on

Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer


Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI

Walmart To Host Fourth Quarter Earnings Conference Call February 20th, 2025
Walmart To Host Fourth Quarter Earnings Conference Call February 20th, 2025


Walmart Inc. (NYSE: WMT) announced it will hold a live conference call with the investment community at 7 a.m. CST on Thursday, Feb. 20, 2025, to discuss the company's fourth quarter and full-year

U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma


Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in

Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)


Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3 EV-302 clinical trial (also

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance
Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance


Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial guidance(5) provided on December 17, 2024.



The fourth-quarter 2024

Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial


Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with

Chevron Reports Fourth Quarter 2024 Results
Chevron Reports Fourth Quarter 2024 Results


Chevron Corporation (NYSE: CVX) reported earnings of $3.2 billion ($1.84 per share - diluted) for fourth quarter 2024, compared with $2.3 billion ($1.22 per share - diluted) in fourth quarter 2023

ExxonMobil Announces 2024 Results
ExxonMobil Announces 2024 Results

Exxon Mobil Corporation (NYSE:XOM):

Results Summary


 


 


 


 


 


 


 


 


4Q24


3Q24


Change


vs


3Q24


Dollars in

American Express Declares Dividend on Series D Preferred Stock
American Express Declares Dividend on Series D Preferred Stock


The Board of Directors of American Express Company (NYSE: AXP) declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $8,875.00 per

Engine No. 1, Chevron, and GE Vernova to Power U.S. Data Centers
Engine No. 1, Chevron, and GE Vernova to Power U.S. Data Centers


Engine No. 1 and Chevron U.S.A. Inc. (NYSE: CVX) announced today the formation of a partnership to build a new company to develop scalable, reliable power solutions for United States (U.S.) based

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium


Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking

Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer


Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6

American Express Announces Record FY 2024 Revenue, Up 9%, or 10% on an FX-Adjusted Basis
American Express Announces Record FY 2024 Revenue, Up 9%, or 10% on an FX-Adjusted Basis


American Express Company (NYSE: AXP) today reported full year net income of $10.1 billion, or $14.01 per share, compared with net income of $8.4 billion, or $11.21 per share, a year ago.

Chevron Achieves First Oil at Future Growth Project in Kazakhstan
Chevron Achieves First Oil at Future Growth Project in Kazakhstan


Chevron Corporation (NYSE: CVX) announced today that its 50 percent owned affiliate Tengizchevroil LLP (TCO) has started oil production at its Future Growth Project (FGP) located at the Tengiz oil

ExxonMobil to Release Fourth Quarter 2024 Financial Results
ExxonMobil to Release Fourth Quarter 2024 Financial Results


Exxon Mobil Corporation (NYSE: XOM) will release its fourth quarter 2024 financial results on Friday, January 31, 2025. The company will issue a press release via Business Wire that will be

Chevron Announces $1 Million Donation to Los Angeles County Wildfire Relief Efforts
Chevron Announces $1 Million Donation to Los Angeles County Wildfire Relief Efforts


Chevron Corporation (NYSE: CVX) today announced a total contribution of $1 million to the California Fire Foundation, American National Red Cross, and the Los Angeles Chamber of Commerce Small

Brightmark RNG Holdings Achieves Landmark First Gas Milestone at 10 Midwest RNG Projects
Brightmark RNG Holdings Achieves Landmark First Gas Milestone at 10 Midwest RNG Projects


Brightmark RNG Holdings LLC announced today that it has delivered first gas at 10 renewable natural gas (RNG) projects across the Midwest. Brightmark RNG Holdings LLC is a joint venture between

American Express to Participate in UBS Financial Services Conference
American Express to Participate in UBS Financial Services Conference


American Express Company (NYSE: AXP) will participate in the UBS Financial Services Conference on Monday, February 10, 2025, at 10:30 a.m. Eastern.



A live audio webcast of a discussion about the

Chevron Names Laura Lane Vice President and Chief Corporate Affairs Officer; Al Williams to Retire
Chevron Names Laura Lane Vice President and Chief Corporate Affairs Officer; Al Williams to Retire


Chevron Corporation (NYSE: CVX) today announced Laura Lane will become vice president and Chief Corporate Affairs Officer, effective February 1. Lane will oversee the company’s government affairs